In this year's competition, the treatment target is “Lung Cancer” and the candidates are as follows; Genetic and Epigenetic Approaches: CRISPR and similar gene editing technologies and epigenetic editing approaches, Cellular and Molecular Therapies: Advanced molecular therapies such as immunotherapy, smart drugs, tumor targeted antibodies, CAR-T cell therapies and transgenic Natural Killer (NK) cells, Artificial Intelligence Assisted Drug Development Solutions: Identification of personalized and cancer-specific targets with artificial intelligence applications, biomarker-based drug development processes and Therapeutic Cancer Vaccine Technologies: Studies are expected in the fields of RNA and DNA-based treatment methods and new generation cancer vaccine technologies.
A New Era Begins in Cancer Treatment with the “3T Competition in Oncology”
The “3T Competition in Oncology” will bring together scientists and students to shape the treatment technologies of the future today. Undergraduate, graduate and doctoral students studying in Turkey and abroad will be able to participate as team members in the competition, which aims to make a difference with creative solutions and innovative ideas, especially in a vital field such as lung cancer. Doctoral graduates can only take part in the projects as team advisors. The winners will receive a total of 600 thousand TL in prize money. Applications for the competition, which has a deadline of February 20, 2025, will be made via the
Oncology3T website.
